You are here

Home

Clinical Trials: Urological Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, July 22, 2021 - 12:00
The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction
Conditions:   Urologic Diseases;   Erectile Dysfunction With Diabetes Mellitus
Interventions:   Biological: stem cells;   Other: placebo
Sponsor:   Indonesia University
Recruiting
Posted: Thursday, February 25, 2021 - 12:00
Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine
Condition:   Chronic Kidney Allograft Nephropathy
Intervention:   Drug: Valsartan 80Mg Oral Tablet
Sponsor:   Josep M Cruzado
Recruiting
Posted: Thursday, January 28, 2021 - 12:00
Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients
Conditions:   Urinary Incontinence;   Epispadias, Male
Interventions:   Biological: Primary human muscle stem cells (Satori-01);   Other: Placebo
Sponsors:   Simone Spuler;   German Federal Ministry of Education and Research
Not yet recruiting
Posted: Friday, October 30, 2020 - 12:00
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis
Conditions:   Interstitial Cystitis;   Stem Cell Transplant;   Mesenchymal Stem Cell
Intervention:   Drug: MR-MC-01
Sponsors:   Asan Medical Center;   MIRAE CELL BIO
Recruiting
Posted: Monday, October 19, 2020 - 12:00
Stem Cells for Uremic Calciphylaxis Patients
Conditions:   Chronic Kidney Diseases;   Calciphylaxis;   Calcific Uremic Arteriolopathy;   Treatment
Intervention:   Other: Human amniotic mesenchymal stem cells
Sponsor:   Ningning Wang
Recruiting
Posted: Thursday, September 24, 2020 - 12:00
Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy
Condition:   Diabetic Nephropathy
Interventions:   Drug: UC-MSCs;   Drug: Placebo
Sponsors:   Renmin Hospital of Wuhan University;   Wuhan Hamilton Biotechnology Co., Ltd
Recruiting
Posted: Wednesday, June 24, 2020 - 12:00
A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy
Conditions:   COVID-19;   Acute Kidney Injury
Interventions:   Biological: SBI-101;   Device: Sham
Sponsor:   Sentien Biotechnologies, Inc.
Not yet recruiting
Posted: Monday, May 18, 2020 - 12:00
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
Condition:   End Stage Renal Disease
Intervention:   Drug: Adipose Derived Mesenchymal Stem Cells
Sponsor:   Albert Hakaim
Not yet recruiting
Posted: Friday, May 15, 2020 - 12:00
Placebo-Controlled Trial of Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)
Conditions:   BK Virus Infection;   Hemorrhagic Cystitis
Interventions:   Biological: Viralym-M;   Biological: Placebo
Sponsor:   AlloVir
Not yet recruiting
Posted: Friday, January 3, 2020 - 12:00
Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy
Condition:   Type 2 Diabetes With Renal Manifestations
Interventions:   Biological: human umbilical cord mesenchymal stem cells;   Other: saline
Sponsor:   Shanghai East Hospital
Recruiting

Pages